Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library
Full article: Perioperative blood loss and gastrointestinal tolerability of etoricoxib and diclofenac in total hip arthroplasty (ETO-DIC study): a single-center, prospective double-blinded randomized controlled trial
Figure 2 from Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). | Semantic Scholar
Etoricoxib versus diclofenac for myocardial infarction. CI, confidence... | Download Scientific Diagram
A Randomized Double-Blind Comparative Study of Efficacy and Safety Between Low-Dose Etoricoxib and Ibuprofen Coadministered with Low-Dose Paracetamol for Dental Pain - Kothari Saroj, Bansal Haresh, Paharia Yogendra, 2022
Testimony Concerning Etoricoxib (Arcoxia) - Public Citizen
Etoricoxib versus diclofenac for major vascular events. CI, confidence... | Download Scientific Diagram
Full article: Perioperative blood loss and gastrointestinal tolerability of etoricoxib and diclofenac in total hip arthroplasty (ETO-DIC study): a single-center, prospective double-blinded randomized controlled trial
Etoricoxib Pain Relief, 30 Gram
Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta‑analysis of randomized, double‑blinded, controlled trials
Figure 3 | Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway
Effects of multiple dosing of etoricoxib, diclofenac, or indomethacin... | Download Scientific Diagram
NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same? | Journal of Pharmacology and Experimental Therapeutics
Efficacy of Etoricoxib, Celecoxib, Lumiracoxib, Non-Selective NSAIDs, and Acetaminophen in Osteoarthritis: A Mixed Treatment Comparison
Etoricoxib versus diclofenac for hypertension. CI, confidence interval. | Download Scientific Diagram
![PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/58842943eddcb944204ee81faa180de7be874471/6-Figure2-1.png "PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar")
PDF] Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Semantic Scholar
COMPARATIVE EFFICACY OF COMBINED USE OF DICLOFENAC WITH THIOCOLCHICOSIDE AND DICLOFENAC ALONE IN ORTHOPEDIC PATIENTS | Semantic Scholar
Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II) | Annals of the Rheumatic Diseases
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | SpringerLink
![Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489] | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2474-6-58/MediaObjects/12891_2004_Article_171_Fig1_HTML.jpg "Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489] | BMC Musculoskeletal Disorders | Full Text")
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489] | BMC Musculoskeletal Disorders | Full Text
Heart Failure Factors in Patients on Etoricoxib or Diclofenac
Effects of treatment with diclofenac or etoricoxib on alveolar bone... | Download Scientific Diagram
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | SpringerLink
Effectiveness of diclofenac, ketorolac and etoricoxib in the treatment of acute pain from ankle fracture. | Semantic Scholar
![JAMA on X: "In this cohort study, patients given tramadol for OA had higher all-cause mortality compared to those given other commonly prescribed NSAIDs (naproxen, diclofenac, celecoxib, etoricoxib). Learn more at [LINK]](https://pbs.twimg.com/media/D1oYYbiWsAAklxD.png "JAMA on X: \"In this cohort study, patients given tramadol for OA had higher all-cause mortality compared to those given other commonly prescribed NSAIDs (naproxen, diclofenac, celecoxib, etoricoxib). Learn more at [LINK]")